Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2

Another bad quarterly as expected. No real update on when the foxconn manufacturing will start, which is the only time I can see this possibly turning around. Have to assume this quarter now but much later than thought. Spirosonic cleared for sale in the US. I would have thought that would have been announced when it happened rather than included in one sentence in a quarterly. Good to see some money going to marketing and sales but has it helped. No info re this ehealth that was supposed give first revenue this half from memory.